Submitting OIG:
Report Description:
Previous OIG work found that Medicaid may have paid for drugs in 2008 that were not approved by the Food and Drug Administration (FDA) as safe and effective. To qualify for Federal payments under Medicaid, drugs must be FDA-approved unless they meet the criteria for an exception-for example, prescription prenatal vitamins or drugs that are prescribed during times of drug shortages.
Date Issued:
Friday, May 3, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
OEI-03-17-00120
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Inspection / Evaluation
View Document:
Attachment | Size |
---|---|
oei-03-17-00120.pdf | 2.08 MB |
Additional Details Link: